Nanotechnology could recover energy
Scientists Create Piezoelectric Generators from Bacteriophage Thin Films

Mequon company - Endece LLC - may be on the verge of CURING MS

By Alysha Schertz

Multiple sclerosis is a debilitating, often deadly disease that attacks the body's central nervous system. It can devastate a victim's brain, spinal cord, optic nerves and vision.

Approximately 400,000 people in the United States are living with MS. Worldwide, more than 2.1 million people are afflicted with the disease, many with different symptoms and levels of severity.

The disease is unpredictable. While treatments and medication currently on the market can help slow down the attacks, there is no cure.


But the cure for MS just might be sitting right in southeastern Wisconsin's backyard.

Endece LLC, a Mequon-based drug discovery company, recently formed Endece Neural, a subsidiary company focused on neurological drug development. More specifically, Endece Neural is pursing the development of a drug that could help repair and even reverse the damage caused by MS.

Endece's work is getting some attention in the world of MS research.

Full story.

Please visit our sponsor Gehrke & Associates, SC to learn more about how to enhance and defend your intellectual property.  Thank you.